Viewing Study NCT00612118


Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-03-01 @ 8:12 PM
Study NCT ID: NCT00612118
Status: COMPLETED
Last Update Posted: 2012-06-05
First Post: 2008-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module